Citations

Showing 10 of 108119 citations.

Re-exposure to blinatumomab after CD19-positive relapse: Experience from three trials in patients (pts) with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R ALL).
Topp, Max S. , Stelljes, Matthias , Barnette, Phillip, Heffner, Leonard T., Trippett, Tanya, Bargou, Ralf C. , Holland, Chris, Litzow, Mark R. , Zugmaier, Gerhard , Benjamin, Jonathan

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7051-7051

10.1200/jco.2015.33.15_suppl.7051 Get It

Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Faderl, Stefan, Pagel, John M. , Yoon, Sung‐Soo, Pardanani, Animesh , Hauptschein, Robert, Lee, Kyoung-June, Cortes, Jörge E. , Jung, Chul Won , Yoon, Sung‐Soo , Koh, Youngil , Lee, Je‐Hwan

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7044-7044

10.1200/jco.2015.33.15_suppl.7044 Get It

Safety and tolerability of the combination of ATRA + arsenic trioxide (ATO) + gemtuzumab ozogamicin (GO) in high-risk acute promyelocytic leukemia (APL): Initial report of the SWOG/Alliance/ECOG S0535 trial.
Tallman, Martin S. , Litzow, Mark R. , Appelbaum, Frederick R. , Lancet, Jeffrey E. , Othus, Megan , DeAngelo, Daniel J. , Coutré, Steven , Komrokji, Rami S.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7016-7016

10.1200/jco.2015.33.15_suppl.7016 Get It

A phase II, randomized trial of standard of care with or without midostaurin to prevent relapse following allogeneic stem cell transplantation in patients with FLT3-ITD mutated acute myeloid leukemia.
Scott, Bart L. , Deol, Abhinav , Patnaik, Mrinal M. , Haines, Kelly, Elliott, Brian , Paley, Carole, Fernández, Hugo F. , Maziarz, Richard Thomas , Mohan, Sanjay

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: TPS7094-TPS7094

10.1200/jco.2015.33.15_suppl.tps7094 Get It

Results of a first-in-human, phase I/II trial of ASP2215, a selective, potent inhibitor of FLT3/Axl in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML).
Perl, Alexander E. , Altman, Jessica K. , Ritchie, Ellen K. , Baer, Maria R. , Litzow, Mark R. , Schiller, Gary J. , Üstün, Celalettin , Gill, Stan, Sargent, Briana, Bahceci, Erkut, Levis, Mark J. , Cortes, Jörge E. , Larson, Richard A. , Smith, Catherine C. , Wang, Eunice S. , Strickland, Stephen Anthony , Claxton, David F. , Liu, Charles Y.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7003-7003

10.1200/jco.2015.33.15_suppl.7003 Get It

Targeting the C5 subclass of high-grade serous ovarian cancer using patient-derived xenografts: Microtubule polymerisation inhibitors.
Heong, Valerie , Topp, Monique, Ananda, Sumitra, McNally, Orla , Lindeman, Geoffrey John, Ruby, Huang, Haluska, Paul , Wakefield, Matthew J. , Swisher, Elizabeth M. , Tan, David S.P. , Bowtell, David D.L. , Scott, Clare L.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e22202-e22202

10.1200/jco.2015.33.15_suppl.e22202 Get It

Quantitation of CD11c+ dendritic cells normal breast tissue and benign breast disease.
Arshad, Muhammad Asad, Visscher, Daniel W., Brahmbhatt, Rushin D., Jimenez, Alvaro Pena, Frost, Marlene H., Miller, Erin , Knutson, Keith L. , Hoskin, Tanya L. , Stallings‐Mann, Melody , Murphy, Linda, Winham, Stacey J. , Carter, Jodi M. , Radisky, Derek C. , Knutson, Keith L. , Degnim, Amy C.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e22115-e22115

10.1200/jco.2015.33.15_suppl.e22115 Get It

ClearCell FX Microfluidic System for the Enrichment and Genetic Analysis of Circulating Tumor Cells.
Punia, Sohan, Bi, Lintao , Jang, Jin Sung , Campion, Michael B., Voss, Jesse S. , Kipp, Benjamin R. , Grothey, Axel, Boardman, Lisa A., Wigle, Dennis A. , Halling, Kevin C. , Liu, Minetta C. , Jen, Jin , Turker, Mehmet Akif, Boardman, Lisa A.

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e22023-e22023

10.1200/jco.2015.33.15_suppl.e22023 Get It

Applying a mitotic index to circulating tumor cells and its prognostic significance: A cytological approach to patient stratification.
Chumsri, Saranya , Charpentier, Monica S., Alpaugh, R. Katherine , Tang, Cha‐Mei , Haudenschild, Christian C., Adams, Daniel L. , Martin, Stuart S. , Cristofanilli, Massimo

Mayo Clinic

Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 11029-11029

10.1200/jco.2015.33.15_suppl.11029 Get It